Background illustration for clinical trials search

Paid Clinical Trials Chicago

Discover 2,373 paid clinical trials in Chicago, Illinois. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.

Filter
2

Testing the Combination of Anti-cancer Drugs Mosunetuzumab, Polatuzumab Vedotin, and Lenalidomide for the Treatment of Relapsed/Refractory Diffuse Large B-Cell Lymphoma

for
Diffuse Large B-Cell Lymphoma, Not Otherwise Specified,
Location: Chicago IL, Cleveland OH, Charlottesville VA,
Sponsor: National Cancer Institute (NCI)

Sex: All

Age: 18+

Code: NCT06015880

Phase1, Recruiting

Procedural Framing and Epidural Steroid Injection Outcomes

for
Lumbosacral Radiculopathy
Location: Chicago IL
Sponsor: Northwestern University

Sex: All

Age: 0+

Code: NCT07498140

Recruiting

Phase 4 Study: Long-term Safety and Efficacy of NT-501 in MacTel Type 2, Including Sham Procedure Participants

for
Macular Telangiectasia Type 2 (MacTel)
Location: Chicago IL, Grand Rapids MI, Cincinnati OH,
Sponsor: Neurotech Pharmaceuticals

Sex: All

Age: 18+

Code: NCT06971939

Recruiting

Selenium Supplementation in Moderate-Severely Active Ulcerative Colitis Patients Treated With Advanced Therapies

for
Ulcerative Colitis (UC)
Location: Chicago IL
Sponsor: Northwestern University

Sex: All

Age: 18 - 70+

Code: NCT07427017

Phase2, Recruiting

A Study to Investigate Sonrotoclax (BGB-11417) Plus Zanubrutinib (BGB-3111) Compared With Venetoclax Plus Acalabrutinib in Adults With Previously Untreated Chronic Lymphocytic Leukemia

for
Chronic Lymphocytic Leukemia
Location: Chicago IL, Zion IL, Milwaukee WI, Rochester MN,
Sponsor: BeOne Medicines

Sex: All

Age: 18+

Code: NCT07277231

Phase3, Recruiting

Interested in new trials?

Get alerts for new trials in your area by subscribing now

Subscriber Image

Inotuzumab Ozogamicin and Blinatumomab With or Without Ponatinib in Treating Patients With Newly Diagnosed, Recurrent, or Refractory CD22-Positive B-Lineage Acute Lymphoblastic Leukemia

for
B Acute Lymphoblastic Leukemia, Philadelphia Chromosome Negative,
Location: Chicago IL, Maywood IL, Evanston IL, Glenview IL,
Sponsor: National Cancer Institute (NCI)

Sex: All

Age: 18+

Code: NCT03739814

Phase2, Recruiting

Testing the Addition of Paclitaxel Administered Into the Abdominal Cavity Combined With Chemotherapy for Patients With Gastric Cancer Spread to the Abdominal Cavity

for
Gastric Adenocarcinoma,
Location: Chicago IL, Oak Brook IL, Warrenville IL, Geneva IL,
Sponsor: ECOG-ACRIN Cancer Research Group

Sex: All

Age: 18+

Code: NCT07001748

Phase2, Phase3, Recruiting

Genomic Predictors of Recurrent Pregnancy Loss

for
Recurrent Pregnancy Loss
Location: Chicago IL, Detroit MI, Hershey PA, Baltimore MD,
Sponsor: Yale University

Sex: All

Age: 18 - 50

Code: NCT05444283

Recruiting

Comparing New Treatments for People With Newly Diagnosed Acute Myeloid Leukemia That Has an IDH2 Gene Change (A MyeloMATCH Treatment Trial)

for
Acute Myeloid Leukemia
Location: Chicago IL, Maywood IL, Hines IL, Evanston IL,
Sponsor: National Cancer Institute (NCI)

Sex: All

Age: 18+

Code: NCT06672146

Phase2, Recruiting

Clinical Trial of Omalizumab for Allergen Sensitized and Exposed Individuals With COPD

for
Chronic Obstructive Pulmonary Disease (COPD), Allergies
Location: Chicago IL, Ann Arbor MI, Pittsburgh PA, Kansas City KS,
Sponsor: Johns Hopkins University

Sex: All

Age: 40+

Code: NCT07059091

Phase2, Recruiting

Electrophysiological Representations of Odor Identity Study 2

for
Odor Identity Ratings
Location: Chicago IL
Sponsor: Northwestern University

Sex: All

Age: 12 - 65

Code: NCT07386236

Recruiting

Testing Shorter Duration Radiation Therapy Versus the Usual Radiation Therapy in Patients Receiving the Usual Chemotherapy Treatment for Bladder Cancer, ARCHER Study

for
Muscle Invasive Bladder Urothelial Carcinoma,
Location: Chicago IL, Oak Park IL, Orland Park IL,
Sponsor: NRG Oncology

Sex: All

Age: 18+

Code: NCT07097142

Phase3, Recruiting

Family Navigator Plus for Foster Parents

for
Intervention
Location: Chicago IL
Sponsor: Northwestern University

Sex: All

Age: 18+

Code: NCT06978959

Recruiting

Testing the Addition of Chemotherapy or Chemo-Immunotherapy to the Usual Surgery for Advanced Head and Neck Cancer

for
Clinical Stage II HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8,
Location: Chicago IL, Oak Brook IL, Glenview IL, Orland Park IL,
Sponsor: National Cancer Institute (NCI)

Sex: All

Age: 18+

Code: NCT07195734

Phase2, Recruiting

Radiotherapy to Block Oligoprogression In Metastatic Non-Small-Cell Lung Cancer

for
Non-small Cell Lung Cancer
Location: Chicago IL, Oak Brook IL, Glenview IL, Orland Park IL,
Sponsor: Canadian Cancer Trials Group

Sex: All

Age: 18+

Code: NCT06686771

Phase3, Recruiting

WP1066 and Radiation Therapy in Treating Patients With Newly Diagnosed Glioblastoma

for
Glioblastoma, IDH-Wildtype, MGMT-Unmethylated Glioblastoma
Location: Chicago IL
Sponsor: Northwestern University

Sex: All

Age: 18+

Code: NCT05879250

Phase2, Recruiting

A Study to Evaluate the Efficacy and Safety of Cannabidiol Oral Solution (CBD-OS [GWP42003-P, JZP926]) for the Treatment of Focal-Onset Seizures

for
Focal Seizures
Location: Chicago IL, Detroit MI, Cincinnati OH, Memphis TN,
Sponsor: Jazz Pharmaceuticals

Sex: All

Age: 12 - 70+

Code: NCT07233239

Phase1, Recruiting

Correlation Between an Impedance Cardiography Test for Decompensation and the Development of Left Ventricular Replacement Fibrosis

for
Aortic Stenosis
Location: Chicago IL
Sponsor: Dermed Diagnostics, Inc.

Sex: All

Age: 18+

Code: NCT07230964

Recruiting

PREACTIVE: Preconditioning Exercise Intervention to Improve Symptoms and Quality of Life in Comorbid Atrial Fibrillation and HFpEF

for
Atrial Fibrillation (AF), Atrial Fibrillation (Paroxysmal),
Location: Chicago IL
Sponsor: Northwestern University

Sex: All

Age: 60 - 70+

Code: NCT07324772

Recruiting

A Study of the Efficacy and Safety of Danicamtiv in Participants With Symptomatic Genetic and Familial Dilated Cardiomyopathy

for
Symptomatic Genetic Dilated Cardiomyopathy
Location: Chicago IL, Detroit MI, Cincinnati OH, St Louis MO,
Sponsor: Kardigan, Inc.

Sex: All

Age: 18+

Code: NCT07210723

Phase2, Phase3, Recruiting

Chicago is a vital city for clinical research, offering a robust healthcare network and renowned medical research institutions. Major facilities such as The University of Chicago Medicine, Northwestern Medicine, and Rush University Medical Center are at the forefront of pioneering research across various fields, including cancer, cardiovascular health, and neurological disorders.

Why choose Chicago for clinical trials?

The city of Chicago offers many advantages for individuals considering participation in clinical trials. With a diverse and vibrant population, researchers benefit from the variety of participants, improving the reliability and applicability of research findings across different demographics.

By opting to participate in a clinical trial in Chicago, individuals not only gain access to cutting-edge therapies and treatments but also contribute to vital medical research. This collaborative effort is supported by a robust clinical research infrastructure, ensuring participants receive high-quality care and attention while playing a crucial role in shaping the future of healthcare.

Common conditions studied in Chicago

Local regulations and guidelines

Benefits of participating in clinical trials

How to enroll in a clinical trial in Chicago